Shareholders Agreements and Shareholders' Remedies Contract Versus Statute?

by Michael J Duffy

Protection of Companies From Shareholder Class Actions Through Constitutional Amendment: Is This Possible Or Desirable?

by Michael J Duffy

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA

by Michael J Duffy, Enda W McDermott, John Crown
Published 2018-05-01

Exploring the Glycosylation of Serum CA125

by Pauline M. Rudd, Michael J. Duffy, Giuliano Elia, Weston B. Struwe, Kieran Wynne, Radka Saldova
Published 2013-07-01

The Mutant p53-Targeting Compound APR-246 Induces ROS-Modulating Genes in Breast Cancer Cells

by Naoise C. Synnott, Stephen F. Madden, Vladimir J.N. Bykov, John Crown, Klas G. Wiman, Michael J. Duffy
Published 2018-12-01

HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells

by Martina S. J. McDermott, Neil Conlon, Brigid C. Browne, Adam Szabo, Naoise C. Synnott, Neil A. O’Brien, Michael J. Duffy, John Crown, Norma O’Donovan
Published 2019-02-01

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

by Patricia Gaule, Nupur Mukherjee, Brendan Corkery, Alex J. Eustace, Kathy Gately, Sandra Roche, Robert O’Connor, Kenneth J. O’Byrne, Naomi Walsh, Michael J. Duffy, John Crown, Norma O’Donovan
Published 2019-04-01